SergeA.JabbourMD

PubMed

• Continuous Glucose Monitoring Profiles and Health Outcomes after Dapagliflozin Plus Saxagliptin vs Insulin Glargine.
  Testa, M., Ekholm, E., Su, M., Vilsbøll, T., Lind, M., Simonson, D., Jabbour, S.> ;The Journal of Clinical Endocrinology and Metabolism. 2024 Feb 27
• 3 citations
  Physicians' Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors.
  Serge A Jabbour, Nasrien E Ibrahim, Christos P Argyropoulos> ;Journal of Clinical Medicine. 2022 Oct 13
• 3 citations
  Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis.
  Jean-Etienne Poirrier, Juliana L Meyers, Saurabh P Nagar, Brandon J Patterson, Lisa I Glasser, Serge A Jabbour> ;Diabetes Care. 2022 Nov 1
• 10 citations
  Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice.
  Kamlesh Khunti, Serge Jabbour, Xavier Cos, Sunder Mudaliar, Christian Mende, Marc Bonaca, Paola Fioretto> ;Diabetes, Obesity & Metabolism. 2022 Jul 1
• 16 citations
  Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis.
  Anders L Carlson, Timothy Dilon Daniel, Andrea DeSantis, Serge Jabbour, Esra Karslioglu French, Davida Kruger, Eden Miller, Kerem Ozer, Tom Elliott> ;BMJ Open Diabetes Research & Care. 2022 Jan 1
• 4 citations
  Assessing the impact of medically tailored meals and medical nutrition therapy on type 2 diabetes: Protocol for Project MiNT.
  Kristin L. Rising, Mackenzie Kemp, Patricia Davidson, Judd E. Hollander, Serge Jabbour, Eric Jutkowitz, Benjamin E. Leiby, Cheryl C. Marco, Ian McElwee, Geoffrey Mills...> ;Contemporary Clinical Trials. 2021 Jul 24
• Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease.
  Cristian Guja, Juan P. Frias, Lisa J. Suchower, Elise Hardy, Galina Marr, C. David Sjöström, Serge Jabbour> ;Diabetes Therapy. 2020 Dec 1
• 25 citations
  Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial.
  Serge Jabbour, Juan P. Frias, Azazuddin Ahmed, Elise Hardy, Jasmine Choi, C. David Sjöström, Cristian Guja> ;Diabetes Care. 2020 Aug 18
• 2 citations
  Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
  Cristian Guja, Juan P. Frias, Lisa J. Suchower, Elise Hardy, Galina Marr, C. David Sjöström, Serge Jabbour> ;Diabetes Therapy. 2020 Apr 18
• 42 citations
  Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes
  Amalia Gastaldelli, Enrico Repetto, Cristian Guja, Elise Hardy, Jenny Han, Serge Jabbour, Ele Ferrannini> ;Diabetes, Obesity & Metabolism. 2020 Mar 1
• 1 citations
  Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type ...
  Tina Vilsbøll, Ella Ekholm, Eva Johnsson, Ricardo García-Sánchez, Nalina Dronamraju, Serge Jabbour, Marcus Lind> ;Diabetes, Obesity & Metabolism. 2020 Jan 31
• 3 citations
  Scleromyxedema in a patient with thyroid disease: an atypical case or a case for revised criteria?
  Ezra Hazan, Thomas D. Griffin, Serge Jabbour, Matthew C. Keller> ;Cutis. 2020 Jan 1
• 3 citations
  Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study.
  Ele Ferrannini, Simona Baldi, Juan P. Frias, Cristian Guja, Elise Hardy, Enrico Repetto, Serge Jabbour, Ralph A. DeFronzo> ;Diabetes, Obesity & Metabolism. 2020 Jan 1
• 2 citations
  Pancytopenia and Lymphoid Organ Hyperplasia in a Patient with Graves Disease: Response to Antithyroid Drug Therapy
  Jonathan C. Li, Deepika Nandiraju, Serge Jabbour, Alan A. Kubey> ;AACE Clinical Case Reports. 2019 Aug 28
• 5 citations
  Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therap...
  Tina Vilsbøll, Ella Ekholm, Eva Johnsson, Nalina Dronamraju, Serge Jabbour, Marcus Lind> ;Diabetes Care. 2019 Jun 4
• 62 citations
  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
  Teodor T. Postolache, Laura del Bosque-Plata, Serge Jabbour, Michael J. Vergare, Rongling Wu, Claudia Gragnoli> ;American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 2019 Feb 6
• 61 citations
  Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Contro...
  Serge Jabbour, Juan P. Frias, Elise Hardy, Azazuddin Ahmed, Hui Wang, Peter Öhman, Cristian Guja> ;Diabetes Care. 2018 Oct 1
• 165 citations
  Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
  Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter A. Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C. Bain, Serge Jabbour, Niki Arya, Lars Hans...> ;Diabetes Care. 2018 Jul 18
• 20 citations
  Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with t...
  Juan P. Frias, Elise Hardy, Azazuddin Ahmed, Peter Öhman, Serge Jabbour, Hui Wang, Cristian Guja> ;Diabetes, Obesity & Metabolism. 2018 Jun 1
• 4 citations
  Evaluation of an Ongoing Diabetes Group Medical Visit in a Family Medicine Practice
  Amy Cunningham, David J. Delgado, Joseph Jackson, Albert G. Crawford, Serge Jabbour, Robert D. Lieberthal, Victor Diaz, Marianna LaNoue> ;Journal of the American Board of Family Medicine. 2018 Mar 1
• 103 citations
  Dapagliflozin in patients with type 2 diabetes mellitus:a pooled analysis of safety data from phase IIb/III clinical trials
  Serge Jabbour, Jochen Seufert, André Scheen, Clifford J. Bailey, Cathrina Karup, Anna Maria Langkilde> ;Diabetes, Obesity & Metabolism. 2018 Mar 1
• 35 citations
  Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study
  Cristian Guja, Juan P. Frias, Anikó Somogyi, Serge Jabbour, Hui Wang, Elise Hardy, Julio Rosenstock> ;Diabetes, Obesity & Metabolism. 2018 Jul 1
• 34 citations
  Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, ...
  Serge Jabbour, Juan P. Frias, Cristian Guja, Elise Hardy, Azazuddin Ahmed, Peter Öhman> ;Diabetes, Obesity & Metabolism. 2018 Jun 1
• 39 citations
  Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control.
  Noam Shohat, Majd Tarabichi, Eric H. Tischler, Serge Jabbour, Javad Parvizi> ;The Journal of Bone and Joint Surgery. American Volume. 2017 Nov 15
• 87 citations
  Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: An analysis of the NHANES ...
  Herve Caspard, Serge Jabbour, Niklas Hammar, Peter Fenici, John J. Sheehan, Mikhail Kosiborod> ;Diabetes, Obesity & Metabolism. 2018 Mar 1
• Join now to see all

Journal Articles

• Safety and Efficacy of Exenatide Once Weekly plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients with Type 2 Diabetes Inadequately Contro...  
  Serge Jabbour, MD, Diabetes Care
• Dapagliflozin in Type 2 Diabetes: Effectiveness Across the Spectrum of Disease and Over Time  
  Parikh S, Wilding J, Jabbour SA, Hardy E, IJCP (International Journal of Clinical Practice), 1/1/2015
• Incidence and Severity of Pancreatogenic Diabetes after Pancreatic Resection  
  Burkhart RA, Gerber SM, Tholey RM, Lamb KM, Somasundaram A, McIntyre CA, Fradkin EC, Ashok AP, Felte RF, Mehta JM, Rosato EL, Lavu H, Jabbour SA, Yeo CJ, and Winter JM, Journal of Gastrointestinal Surgery, 1/1/2015
• An Open Label Randomized Phase II Study of Pasireotide With or Without Everolimus in Castrate-Resistant Chemotherapy-Naïve Prostate Cancer Patients  
  Lin J, Deng A, Hoffman-Censits J, Gibney G, Hyslop T, Miller B, Kilpatrick D, Jabbour S, Kelly WK, Cancer Treatment Communications, 1/1/2015
• SGLT2 Inhibitors to Control Glycaemia in Type 2 Diabetes: A New Approach to an Old Problem  
  Jabbour SA, Postgraduate Medicine, 1/1/2014
• Dapagliflozin as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study  
  Jabbour SA, Hardy E, Parikh S, Sugg J, List J, Diabetes Care, 1/1/2014
• Response to: Dapagliflozin - Do We Need it Registered for Type 2 Diabetes? Letter to the Editor  
  Jabbour SA, Expert Opinion on Pharmacotherapy, 1/1/2014
• Collaboration Designed to Increase Translation of Diabetes Research Outcomes Into Clinical Practice  
  Miller JL, Jabbour SA, Clinical Therapeutics, 1/1/2013
• Dapagliflozin: Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes  
  Jabbour SA, Whaley J, Tirmenstein M, Poucher S, Reilly T, Boulton D, Saye JA, List JF, Parikh S, Postgraduate Medicine, 1/1/2012
• Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus  
  Jabbour S, Ziring B, Postgraduate Medicine, 1/1/2011
• 46, XX SRY-Positive Male Syndrome Presenting with Primary Hypogonadism in the Setting of Scleroderma  
  Velasco G, Savarese V, Sandorfi N, Jimenez SA, Jabbour SA, Endocrine Practice, 1/1/2011
• Subclinical Hyperthyroidism, Current Concepts and Scintigraphic Imaging  
  Intenzo C, Jabbour SA, Miller JL, Ahmed I, Furlong K, Kushen M, Kim SM, Capuzzi DM, Clinical Nuclear Medicine, 1/1/2011
• Contemporary Diagnosis and Management of the Patient with Type 2 Diabetes  
  Jabbour SA, Pennsylvania: Handbooks in Healthcare Co, 1/1/2009
• Late Presentation of Thyrotoxicosis from Functioning Metastases in Metastatic Thyroid Carcinoma  
  Ryan M, Furlong K, Jabbour SA, EndoTrends, 1/1/2009
• Type 2 Diabetes and HbA1c goal: Time for Individualised Therapy  
  Jabbour SA, International Journal of Clinical Practice, 1/1/2009
• Visual Vignette  
  Ahmed I, Jabbour SA, Endocrine Practice, 1/1/2009
• The importance of reducing hyperglycemia whilst preserving insulin secretion – the rationale of SGLT2 inhibition  
  Jabbour SA, US Endocrinology, 1/1/2009
• Type 1 Diabetes in Adults  
  Jabbour SA and Stephens E, New York: Informa Healthcare, 1/1/2008
• Primary care physicians and insulin initiation: Multiple barriers, lack of knowledge or both?  
  Jabbour SA, International Journal of Clinical Practice, 1/1/2008
• Sodium Glucose Co-Transporters 2 Inhibitors: Blocking the Reabsorption of Glucose to Improve Glycemic Control in Diabetics  
  Jabbour SA, Goldstein BJ, International Journal of Clinical Practice, 1/1/2008
• Endocrine Incidentalomas  
  Shirodkar M, Jabbour SA, International Journal of Clinical Practice, 1/1/2008
• A comparison of glycemic variability in CSII versus MDI treated type 1 diabetic patients using CGMS  
  Simon B, Treat V, Marco C, Rosenberg D, Joseph J, Hipszer B, Li Y, Chervoneva I, Padron-Massara L, Jabbour SA, International Journal of Clinical Practice, 1/1/2008
• Diabetes Awareness: Are Resident Physicians and Nurses Adequately Prepared to Manage Diabetes?  
  Rubin DJ, Moshang J, Jabbour SA, Endocrine Practice, 1/1/2007
• Scintigraphic Imaging of Body Neuroendocrine Tumors  
  Intenzo CM, Jabbour SA, Lin HC, Miller JL, Kim SK, Capuzzi DM, Mitchell EP, Radiographics, 1/1/2007
• Hypoglycemia in Hospitalized Patients Treated with Antihyperglycemic Agents  
  Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour SA, Gottlieb J, Journal of Hospital Medicine, 1/1/2007
• Join now to see all

Books/Book Chapters

• International Textbook of Diabetes Mellitus 
  Chapter: Glycated Hemoglobin and Serum Proteins as Tools for Monitoring 
  Page 853 - 874Gerber S, Ahmed I, Stickle D, Jabbour SAEditors: DeFronzo R, Ferranini E, Zimmet P, and Alberti G.Wiley-Blackwell, Oxford, EnglandEdition 4th,2015
• Case Reports in Endocrinology 
  Chapter: Ovarian Leydig Cell Hyperplasia: An Unusual Case of Virilization in a Post-Menopausal Woman 
  Mehta JM, Miller JL, Cannon AJ, Mardekian SK, Kenyon AJ, Jabbour SAHindawi Publishing Corporation2014
• Tarascon Adult Endocrinology Pocketbook 
  Chapter: Hypoglycemia 
  Page 321 - 324Donohue K, Jabbour SAEditors: Laufgraben M and Gopalakrishnan G.2013
• Hall’s Manual of the Skin as a Marker of Underlying Disease 
  Chapter: Endocrine System Disorders 
  Page 155 - 167Mitchell C, Velasco G, Jabbour SAEditors: Hall BJ and Hall JC.People’s Medical Publishing House, CN2011
• Type 1 Diabetes in Adults 
  Simon B, Flood J, Jabbour SAOxford University Press, New York, NY2011
• Metabolic Syndrome: Underlying Mechanisms and Drug Therapies 
  Chapter: Sodium Glucose Co-Transporters 2 Inhibitors 
  Page 359 - 375Ryan M, Jabbour SAEditors: Wang M.John Wiley & Sons Inc, NJ2011
• Lipids, Current Opinion in Endocrinology, Diabetes and Obesity 
  Chapter: Management of Diabetes in the Elderly 
  Page 148 - 152Chiniwala N, Jabbour SAEditors: Rodriguez A.2011
• Emergency Dermatology 
  Chapter: Endocrinologic Emergencies in Dermatology 
  Page 298 - 312Ryan M, Savarese V, Jabbour SAEditors: Wolf R, Davidovici BB, Parish JL, Parish LC.Cambridge University Press, New York, NY2010
• The 5-Minute Urology Consult 
  Chapter: Specialty Editor for Endocrinology 
  Jabbour SAEditors: Gomella LG.Lippincott Williams & Wilkins, Philadelphia, PAEdition 2nd,2010
• Diabetes: Approaches in Disease Management 
  Jabbour SA, Wordell CJCMR Institute, MAEdition 8th,2010
• Diagnosis and Treatment of Cutaneous Paraneoplastic Disorders, Dermatologic Therapy 
  Chapter: Skin Manifestations of Hormone-Secreting Tumors 
  Page 643 - 650Jabbour SAEditors: De Giorgi V.2010
• Cutaneous Manifestations of Endocrine Diseases 
  Chapter: Introduction; Cutaneous Manifestations of Endocrine Diseases 
  Jabbour SAEditors: Krause W.Springer-Verlag, Berlin, Germany2009
• Pharmacology and Therapeutics: Principles to Practice 
  Chapter: Adrenal Disorders 
  Page 623 - 630Hamaker L, Jabbour SAEditors: Waldman S and Terzic A.Saunders Elsevier, Philadelphia, PA2009
• Contemporary Diagnosis and Management of the Patient with Type 2 Diabetes 
  Chapter: Pathophysiology of Hyperglycemia in Type 2 Diabetes 
  Jabbour SAEditors: Jabbour SA.Pennsylvania: Handbooks in Healthcare Co2009
• Rubin’s Pathology 
  Chapter: Obesity, Diabetes Mellitus, and Metabolic Syndrome 
  Page 975 - 988Goldstein BJ, Jabbour SA, Furlong KEditors: Rubin R and Strayer D.Lippincott Williams & Wilkins, Philadelphia, PAEdition 5th,2008
• Avoiding Common Anesthesia Errors 
  Chapter: Consider Insulin Therapy to Correct Perioperative Hyperglycemia in Both Diabetic and Nondiabetic Patients 
  Page 183 - 185Abernethy HA, Jabbour SAEditors: Marcucci C, Cohen NA, Metro DG and Kirsch JR.Lippincott Williams & Wilkins, Philadelphia, PA2008
• Avoiding Common Anesthesia Errors 
  Chapter: Stop Metformin Before Elective Surgery or Intravascular Contrast Dye Study to Decrease the Risk of Lactic Acidosis 
  Page 186 - 187Jabbour SA, Moritz MJEditors: Marcucci C, Cohen NA, Metro D and Kirsch JA.Lippincott Williams & Wilkins, Philadelphia, PA2008
• Medical Management of the Surgical Patient 
  Chapter: Perioperative Management of Endocrine Disorders 
  Page 411 - 452Furlong K, Ahmed I, Jabbour SAEditors: Merli G and Weitz H.Saunders, Elsevier, Philadelphia, PAEdition 3rd,2008
• Women’s Health in Clinical Practice: A Handbook for Primary Care 
  Chapter: Thyroid Disorders 
  Page 251 - 272Farooqi HM, Jabbour SAEditors: Clouse and Sherif K.Humana Press, NJ2008
• A Case-Based Guide to Clinical Endocrinology 
  Chapter: Exenatide in Type 2 Diabetes: Indications and Initiation 
  Page 347 - 352Treat V, Jabbour SAEditors: Davies TF.Humana Press, NJ2008
• Pharmacotherapy of Diabetes: New Developments 
  Chapter: The Glitazones, Lessons So Far 
  Page 87 - 97Shirodkar M, Jabbour SAEditors: Mogensen CE.Springer2007
• Contemporary Diagnosis and Management of the Patient with Type 2 Diabetes 
  Chapter: Parenteral Therapies in Type 2 Diabetes 
  Page 71 - 85Jabbour SAEditors: Goldstein BJ.Handbooks in Healthcare Co, Philadelphia, PA2007
• Contemporary Diagnosis and Management of the Patient with Type 2 Diabetes 
  Chapter: Successful Combination Therapy Strategies 
  Page 86 - 95Jabbour SAEditors: Goldstein BJ.Handbooks in Healthcare Co, Philadelphia, PA2007
• Clinical Diabetes: Translating Research into Practice 
  Chapter: Insulin-Sensitizing and Insulin-Sparing Drugs: Thiazolidinediones and Metformin 
  Page 305 - 321Jabbour SA, Anolik J, Goldstein BJEditors: Fonseca V.Saunders, Elsevier, Philadelphia, PA2006
• Endocrinology in Dermatology 
  Chapter: Rare Syndromes 
  Page 299 - 316Jabbour SA, Davidovici BB, Wolf REditors: Jabbour SA.Clinics in Dermatology2006
• Join now to see all

Abstracts/Posters

• Robust Dose-dependent Glucose Lowering and Body Weight (BW) Reductions with the Novel Oral Formulation of Semaglutide in Patients with early Type 2 Diabetes (T2D)
  Jabbour S, Pieber T, Rosenstock J, Hartoft-Nielsen ML, Højbjerg Hansen OK, Davies M, The Endocrine Society, Boston, MA, 1/1/2016
• Efficacy, patient-reported outcomes and safety of insulin degludec 200 U/mL and insulin glargine in patients with type 2 diabetes (T2D) requiring high-dose insulin
  Warren M, Chaykin L, Jabbour S, Sheikh-Ali M, Thim Hansen C, Rasmussen SR, Norwood P, ADA (American Diabetes Association); 23nd World Diabetes Congress, Boston, MA, 2015; Vancouver, Canada, 2015, 1/1/2015
• Incidence of Radioiodine-induced Gastritis and the Dosage of I-131 Ablation for Differentiated Thyroid Cancer: Results of a Multi-year Analysis
  Intenzo C, Jabbour SA, Miller J, Kim S, Furlong K, Ahmed I, SNMMI (Society of Nuclear Medicine and Molecular Aging) Annual Meeting, Baltimore, MD, 1/1/2015
• Patient characteristics and real world effectiveness of dapagliflozin; an observational analysis of US electronic health records
  Jabbour S, Bell K, Eudicone J, Shatskov A, Katz A, WCIR, 13th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease, Los Angeles, CA, 1/1/2015
• Right Recurrent Laryngeal Nerve Mobilization for Primary Anastomosis following Segmental Resection
  Pribitkin E, DiLorenzo M, Cognetti D, Jabbour SA, Spiegel J, Triological Society, Miami Beach, FL, 1/1/2014
• The incidence of pancreatogenic diabetes after major partial pancreatic resection may be greater than you think
  Burkhart RA, Gerber SM, Tholey R, Lamb K, Somasundaram A, McIntyre C, Fradkin E, Ashok A, Felte R, Mehta J, Rosato EL, Lavu H, Jabbour SA, Yeo CJ, and Winter JM, Digestive Disease Week, Chicago, IL, 1/1/2014
• Dax-1 (NROB1) Mutation with Adrenal Hypoplasia Congenita & Hypogonadotropic Hypogonadism
  Dardi I, Jabbour SA, The Endocrine Society, Chicago, IL, 1/1/2014
• An Unusual Case of Postmenopausal Hyperandrogenism
  Somasundaram A, Jabbour SA, The Endocrine Society, Chicago, IL, 1/1/2014
• Young Patient with Suprasellar Mass Found to Have a Germinoma with Involvement of the Pineal Gland
  Donohue K, Jabbour SA, AACE (American Association of Clinical Endocrinologists), Phoenix, AZ, 1/1/2013
• Work-up of Bilateral Adrenal Nodules in a Patient with Confirmed Cushing’s Syndrome
  Donohue K, Jabbour SA, AACE (American Association of Clinical Endocrinologists), Phoenix, AZ, 1/1/2013
• Enhanced localization of posteriorly-descending superior parathyroid adenomas by SPECT
  Chanappa C, Jabbour SA, Intenzo C, SSMMI (Society of Nuclear Medicine and Molecular Imaging), Vancouver, Canada, 1/1/2013
• Scintigraphic findings of subclinical hyperthyroidism
  Intenzo C, Jabbour SA, SSMMI (Society of Nuclear Medicine and Molecular Imaging), Vancouver, Canada, 1/1/2013
• Ectopic Cushing’s Syndrome from ACTH-Producing Pheochromocytoma
  Gerber S, Jabbour SA, The Endocrine Society, San Francisco, CA, 1/1/2013
• Presumed Familial Late-Onset Medullary Thyroid Cancer in a patient with a germline point mutation, c. 2304 G->T, in RET proto-oncogene codon 768: specific mutation ...
  Gerber S, Jabbour SA, The Endocrine Society, San Francisco, CA, 1/1/2013
• MODY: Are We Missing an Important Diagnosis?
  Somasundaram A, Jabbour SA, The Endocrine Society, San Francisco, CA, 1/1/2013
• Dapagliflozin as part of triple combination therapy helps reduce HbA1c and body weight in patients with Type 2 diabetes
  Jabbour SA, Hardy E, de Bruin TW, Gause-Nilsson I, Rohwedder K, Martin P, Parikh S, ADA (American Diabetes Association), Chicago, IL, 1/1/2013
• Pitfalls in cytopathology of “thyroid”nodules
  Bischoff LA, Curry J, Jabbour SA, Pribitkin E, Miller JL, 83rd Annual Meeting of the American Thyroid Association, San Juan, Puerto Rico, 1/1/2013
• Dapagliflozin as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-week, Randomized, Double-Blind, Placebo-Controlled Study
  Jabbour SA, Hardy E, Sugg J, Parikh S, ADA (American Diabetes Association); EASD (European Association for the Study of Diabetes), Philadelphia, PA, 2012; Berlin, Germany, 2012, 1/1/2012
• Utility of SUV max in differentiating malignant thyroid nodules discovered incidentally on FDG-PET
  Pappas AP, Intenzo CM, Kim SM, Miller JL, Jabbour SA, Cappuzzi DM, Sen U, ACNM/SNM (American College of Nuclear Medicine/Society of Nuclear Medicine), Palm Springs, CA, 1/1/2011
• Unrecognised Skeletal Sarcoidosis Mimicking Metastatic Papillary Thyroid Cancer on FDG Positron Emission Tomography
  Chiniwala N, Ahmed I, Furlong K, Jabbour S, Shirodkar M, and Miller J, AACE (American Association of Clinical Endocrinologists), Boston, MA, 1/1/2010
• Pituitary Carcinoma in a 54-year-old Male
  McCullen MK, Jabbour SA, The Endocrine Society, San Diego, CA, 1/1/2010
• Concurrent resection of pituitary adenoma and planum sphenoidale meningioma in a patient with Cushing's disease: Case report
  Shah G, Mitchell C, Evans J, Jabbour SA, Rosen M, NASBS (North American Skull Base Society), New Orleans, LA, 1/1/2009
• A Case of Early Diagnosis of Acromegaly: Hyperhidrosis as the Clue Symptom
  Velasco G, Jabbour SA, AACE (American Association of Clinical Endocrinologists), Houston, TX, 1/1/2009
• A Case of 46, XX SRY-Positive Male Syndrome in a Patient with Scleroderma
  Velasco G, Savarese V, Jabbour SA, The Endocrine Society, Washington, DC, 1/1/2009
• A Case of De Novo Familial Medullary Thyroid Cancer Complicated by Metastatic Papillary Cancer
  Velasco G, Jabbour SA, The Endocrine Society, Washington, DC, 1/1/2009
• Join now to see all

Lectures

• Guideline-Based Approach to Manage T2DM: Place of SGLT2-Inhibitors 
  Lucknow, India - 1/31/2015
• Improving the Metabolic State in T2DM Patients & Associated Risks 
  Lucknow, India - 1/29/2015
• Glucocorticoids and HPA Axis Suppression 
  Philadelphia, PA - 1/24/2015
• Crack the Case 
  Harrisburg, PA - 1/15/2015
• Diabetes 2015 
  Rehoboth Beach, DE, 2015; Philadelphia, PA, 2015 - 1/1/2015
• From Research Program to Clinical Practice: The Dapagliflozin Journey 
  Multiple Locations, 2013, 2014 - 1/30/2014
• Invokana: Advancing Paradigm Changes in Type 2 Diabetes 
  Chicago, IL - 1/21/2014
• Diabesity & Stroke: Unraveling the Myth 
  Philadelphia, PA - 1/20/2014
• Update in Diabetes 
  Upland, PA, 2010; Philadelphia, PA, 2014 - 1/8/2014
• Closing the Gap in Diabetes Care: Addressing Renal-Mediated Glucose Homeostasis 
  Philadelphia, PA - 1/4/2014
• SGLT2-Inhibitors in the Treatment of Type 2 Diabetes 
  Hong Kong, Hong Kong - 1/4/2014
• Diabetes Education-The Next Step 
  Jameson, NJ - 1/2/2014
• Incretins: Clinical Advantages and Differences of GLP-1 agonists and DPP-4 Inhibitors 
  Cancun, Mexico - 1/14/2013
• New Treatment Option For Adult Patients with Type 2 Diabetes 
  Beirut, Lebanon - 1/6/2013
• Use of Exenatide Extended Release and Type 2 Diabetes 
  Philadelphia, PA - 1/27/2012
• Endocrine Incidentalomas 
  Philadelphia, PA, 2003; Camden, NJ, 2012 - 1/19/2012
• Targeting the Kidney in Managing the Patient with Type 2 Diabetes 
  Baltimore, MD - 1/8/2012
• Thyroid in Pregnancy 
  Philadelphia, PA - 1/7/2012
• Clinical Update: Treating Diabetes 
  Philadelphia, PA - 1/23/2011
• Management of Hypogonadism 
  King of Prussia, PA - 1/22/2011
• Endocrinopathies and the Skin 
  Philadelphia, PA - 1/12/2011
• Diabetes Cases for Discussion 
  Philadelphia, PA - 1/6/2011
• Beyond Insulin: A New Target for Diabetes Management Based on Glucose Reabsorption in the Kidneys 
  Orlando, FL - 1/26/2010
• Case Discussion in Thyroid Cancer 
  Marlton, NJ - 1/22/2010
• Interactive Cases in Diabetes 
  Philadelphia, PA - 1/21/2010
• Join now to see all

Other

• Modern Oral Agents in Clinical Practice: Where do SGLT2 Inhibitors Fit 
  Jabbour SA, Medscape
  http://www.medscape.org/viewarticle/833998
  1/1/2014
• Clinical Decision Support: Dermatology 
  Boban I, Jabbour SA
  1/1/2012
• Syndrome X 
  Jabbour SA, Miller JL, World Book, Inc.
  www.worldbookonline.com
  1/21/2004
• Under-appreciated Risk of Diabetes Mellitus 
  Jabbour SA, Maiese ML
  www.NewsRounds.com
  1/16/2000
• Join now to see all